StonvexLoading…
StonvexStonvexStonvexCore line items from HPQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-25 | Q2 2026 2026-04-30 | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 |
|---|---|---|---|---|---|
Revenue | $13.88B | $28.85B | $14.44B | $55.30B | $40.66B |
Operating Income | Not available | $1.37B | $759.00M | $3.17B | $2.21B |
Net Income | Not available | $995.00M | $545.00M | $2.53B | $1.73B |
EPS (Diluted) | $0.63 | $1.07 | $0.58 | $2.65 | $1.82 |
Total Assets | Not available | $42.94B | $41.53B | $41.77B | $39.85B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $3.70B | $3.15B | $3.69B | $2.87B |
Free Cash Flow OCF − CapEx | Not available | $906.00M | $150.00M | $2.80B | $1.37B |
Shares Outstanding | Not available | 914.00M | 917.00M | 921.00M | 939.00M |